Clinical Trial

Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

Name: Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP — clinical trial record (NCT07057778)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Randomized, open-label, multicentre study to assess the efficacy and safety of the combination of low-dose rituximab and Iguratimod in patients with steroid-resistant/relapsed ITP.

Trial Details

NCT Number	NCT07057778
Lead Sponsor	Peking University People's Hospital Collaborators: Beijing Hospital, Beijing Friendship Hospital, Navy General Hospital, Beijing, Beijing Tongren Hospital
Conditions	Immune Thrombocytopenia (ITP)
Enrollment	120 participants
Start Date	2025-07-01
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-07-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-10